Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series

Conclusion
We report the largest case series of diffuse, sheet-like EDG treated with intraocular MTX with follow-ups up to 10 years. Intraocular MTX may be used effectively to achieve eradication of EDG in cases where surgery is not amenable. However, further recommendations to guide treatment remain warranted.

Source: British Journal of Ophthalmology - August 21, 2023 Category: Opthalmology Authors: Hebert, M., Kyrillos, R., Snyder, M. E., Mackool, R. J., Francis, J. H., Wu, H. K., Riemann, C. D., Legare, M. E. Tags: Original articles - Clinical science Source Type: research